Tdspharm Co., Ltd. (KOSDAQ:464280)

Tdspharm Revenue

Tdspharm had revenue of 8.08B KRW in the quarter ending June 30, 2026, with 44.66% growth. This brings the company's total for the last twelve months to 32.90B, up 43.41% year-over-year. In the year 2025, Tdspharm had annual revenue of 27.62B with 0.37% growth. That makes Tdspharm the 32,557th largest company in the world by revenue and 2,073rd in South Korea.

• Revenue (ttm): 32.90B
• Revenue Growth: +43.41%
• P/S Ratio: 0.74
• Revenue / Employee: n/a
• Employees: n/a
• Market Cap: 24.41B

Revenue Chart

Chart

Chart

Revenue by Segment

• Cataplasma 20.72B 75.3%
• Plasta 4.45B 16.2%
• Excluding Solid Content 2.35B 8.5%

Fiscal year ended Dec 31, 2024 See the full Tdspharm breakdown

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	27.62B	102.10M	0.37%
Dec 31, 2024	27.52B	-2.53B	-8.42%
Dec 31, 2023	30.05B	4.46B	17.43%
Dec 31, 2022	25.59B	5.77B	29.11%
Dec 31, 2021	19.82B	1.80B	9.97%

Data Source: S&P Global Market Intelligence Last updated: Jul 30, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Nov 4, 2026

Data Sources Report a data error